Join Irena Rozyman, for an insightful discussion on the strategic considerations surrounding the “patent dance” under the Biologics Price Competition and Innovation Act (BPCIA).
Orrick is hosting a summit for life sciences and healthtech leaders to explore new financing trends and growth strategies.
The New York Intellectual Property Law Association is hosting their event, “Biologics & Biosimilars: Hot Topics” in Orrick's NY office.
This on-demand CLE shares best practices and priority issues in overcoming regulatory hurdles for healthcare providers and facilities in telemedicine.